NCT01942200View on ClinicalTrials.gov

A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer

CompletedOBSERVATIONAL

Enrollment

383

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 25, 2018

Study Completion Date

July 25, 2018

Conditions

Carcinoma

Trial Locations (3)

01920

Practice, Elstra

04277

Practice, Leipzig

04683

Practice, Naunhof

All Listed Sponsors

collaborator

AKP Freiburg GmbH

INDUSTRY

lead

Onkovis GmbH

INDUSTRY

NCT01942200 - A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer | Biotech Hunter | Biotech Hunter